EVA Pharma of Africa, DNA Script and Quantoom Biosciences have signed a MoU to e...
The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate A...
X-Elio will supply 245GWh of clean energy annually to four pharmaceutical compan...
Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s MHRA, allowin...
Experts at the 2025 Clinical Trial Supply Europe conference will explore supply ...
Microplastics, tiny plastic bits less than five millimetres in size, come from b...
MedPharm has appointed Bill Humphries as its new CEO, marking a significant step...
Jabil has acquired contract development and manufacturing organisation (CDMO) Ph...
Developers celebrate gains for advances with radiopharmaceuticals while regulato...
Telethon Foundation is seeking approval for a gene therapy to treat the rare dis...
The cuts at two Massachusetts plants follow further site closures and layoffs ac...
USC has received a $6m grant from the California Institute for Regenerative Medi...
Immunotherapeutics have transformed cancer outcomes. It is crucial that response...
Southeast Asia had the highest number of cervical and childhood cancers among al...
Vanda and AnaptysBio have announced an exclusive worldwide licence agreement to ...
The EC has authorised the use of ViiV Healthcare’s Vocabria plus Rekambys from J...
